Prenetics Global (PRE) Competitors $4.50 -0.31 (-6.44%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PRE vs. SENS, AKYA, SEER, FEIM, QSI, KEQU, MASS, OWLT, OPXS, and OMICShould you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Senseonics (SENS), Akoya Biosciences (AKYA), Seer (SEER), Frequency Electronics (FEIM), Quantum-Si (QSI), Kewaunee Scientific (KEQU), 908 Devices (MASS), Owlet (OWLT), Optex Systems (OPXS), and Singular Genomics Systems (OMIC). These companies are all part of the "measuring and control equipment" industry. Prenetics Global vs. Senseonics Akoya Biosciences Seer Frequency Electronics Quantum-Si Kewaunee Scientific 908 Devices Owlet Optex Systems Singular Genomics Systems Prenetics Global (NASDAQ:PRE) and Senseonics (NYSE:SENS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, community ranking, dividends, profitability, earnings, valuation and media sentiment. Which has more volatility & risk, PRE or SENS? Prenetics Global has a beta of -0.2, suggesting that its stock price is 120% less volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Which has stronger valuation and earnings, PRE or SENS? Senseonics has higher revenue and earnings than Prenetics Global. Senseonics is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrenetics Global$21.74M1.89-$62.72M-$3.23-1.39Senseonics$22.39M7.49-$60.39M-$0.13-2.18 Do insiders & institutionals believe in PRE or SENS? 25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 12.4% of Senseonics shares are owned by institutional investors. 7.8% of Prenetics Global shares are owned by company insiders. Comparatively, 3.9% of Senseonics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is PRE or SENS more profitable? Prenetics Global has a net margin of -229.17% compared to Senseonics' net margin of -362.30%. Prenetics Global's return on equity of -15.70% beat Senseonics' return on equity.Company Net Margins Return on Equity Return on Assets Prenetics Global-229.17% -15.70% -12.98% Senseonics -362.30%-842.25%-67.99% Do analysts recommend PRE or SENS? Prenetics Global currently has a consensus target price of $9.00, indicating a potential upside of 100.00%. Senseonics has a consensus target price of $2.00, indicating a potential upside of 606.46%. Given Senseonics' higher possible upside, analysts clearly believe Senseonics is more favorable than Prenetics Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prenetics Global 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Senseonics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor PRE or SENS? In the previous week, Prenetics Global had 1 more articles in the media than Senseonics. MarketBeat recorded 4 mentions for Prenetics Global and 3 mentions for Senseonics. Prenetics Global's average media sentiment score of 0.35 beat Senseonics' score of 0.12 indicating that Prenetics Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prenetics Global 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Senseonics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer PRE or SENS? Prenetics Global received 2 more outperform votes than Senseonics when rated by MarketBeat users. Likewise, 83.33% of users gave Prenetics Global an outperform vote while only 9.68% of users gave Senseonics an outperform vote. CompanyUnderperformOutperformPrenetics GlobalOutperform Votes583.33% Underperform Votes116.67%SenseonicsOutperform Votes39.68%Underperform Votes2890.32% SummaryPrenetics Global beats Senseonics on 10 of the 16 factors compared between the two stocks. Ad Darwin2024 Election Year Stocks: Uncover Hidden Gems!In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. Get Prenetics Global News Delivered to You Automatically Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRE vs. The Competition Export to ExcelMetricPrenetics GlobalAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.12M$5.43B$5.10B$8.74BDividend YieldN/A0.46%5.20%4.08%P/E Ratio-1.3910.2470.2415.15Price / Sales1.893.991,247.3886.83Price / CashN/A40.7240.0335.24Price / Book0.202.206.495.93Net Income-$62.72M$515,312.50$116.34M$225.73M7 Day Performance-2.17%-11.04%-5.14%-1.34%1 Month Performance-9.82%-7.68%-2.71%1.15%1 Year Performance-2.60%-16.52%31.26%24.02% Prenetics Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PREPrenetics Global2.1146 of 5 stars$4.50-6.4%$9.00+100.0%-9.6%$41.12M$21.74M-1.391Upcoming EarningsShort Interest ↑Gap DownSENSSenseonics1.6211 of 5 stars$0.28-6.6%N/A-52.6%$168.13M$22.39M-2.1890Analyst ForecastNews CoverageHigh Trading VolumeAKYAAkoya Biosciences2.0015 of 5 stars$3.13-2.5%N/A-47.3%$154.94M$96.63M-2.5490Analyst ForecastShort Interest ↓News CoverageGap DownSEERSeer2.2131 of 5 stars$2.42+4.8%N/A+57.1%$148.66M$16.66M-1.86160Short Interest ↑FEIMFrequency Electronics2.7418 of 5 stars$12.89-0.7%N/A+59.8%$123.36M$55.27M20.79200Short Interest ↓News CoveragePositive NewsQSIQuantum-Si2.4166 of 5 stars$0.78-1.3%N/A-53.7%$110.94M$1.08M-1.22150Analyst ForecastAnalyst RevisionKEQUKewaunee Scientific0.8802 of 5 stars$38.09-0.5%N/A+105.6%$109.32M$203.76M6.111,006Analyst UpgradeShort Interest ↑News CoverageMASS908 Devices2.8115 of 5 stars$2.38+1.7%N/A-61.0%$82.49M$50.23M-1.3460Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeOWLTOwlet1.2257 of 5 stars$4.79-10.5%N/A-19.2%$73.19M$54M-1.83106News CoveragePositive NewsHigh Trading VolumeOPXSOptex Systems1.3304 of 5 stars$8.34-1.0%N/A+99.0%$57.87M$32.63M13.67122Short Interest ↑OMICSingular Genomics Systems1.9986 of 5 stars$22.75+1.0%N/A+71.8%$56.88M$2.91M-0.65220Earnings ReportShort Interest ↓News CoveragePositive News Related Companies and Tools Related Companies SENS Alternatives AKYA Alternatives SEER Alternatives FEIM Alternatives QSI Alternatives KEQU Alternatives MASS Alternatives OWLT Alternatives OPXS Alternatives OMIC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRE) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prenetics Global Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prenetics Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
